However, the observation that DN tend to harbor non-V600E BRAF and NRAS mutations suggests that there are likely to be alternative pathways to Clark’s classically postulated model of a linear step-wise progression to melanoma [4,16]. The gene discussed is NRAS; the disease is melanoma.